icon-folder.gif   Conference Reports for NaTaP  
 
  EASL - The International Liver Congress 2015
50th annual Meeting of the European
association for the Study of the Liver
Vienna, austria  april 22-26
Back grey_arrow_rt.gif
 
 
 
EFFICACY OF AN 8-WEEK REGIMEN OF GRAZOPREVIR PLUS ELBASVIR WITH AND WITHOUT RIBAVIRIN IN TREATMENT-NAIVE, NONCIRRHOTIC HCV GENOTYPE 1B INFECTION
 
 
  Reported by Jules Levin
EASL 2015 April 22-26 Vienna Austria
 
John M. Vierling1, Marcelo Kugelmas2, Eric Lawitz3, Peggy Hwang4, Michael Robertson4, Janice Wahl4, Eliav Barr4,Barbara Haber4
1Baylor College of Medicine, Houston, TX, USA 2South Denver Gastroenterlogy, Englewood, CO, USA
3The Texas Liver Institute, of Texas Health Science Center, San Antonio, TX, USA 4Merck & Co., Inc., Kenilworth, NJ, USA

EASL1.gif

EASL2.gif

EASL3.gif

EASL4.gif

EASL5.gif

EASL6.gif

EASL7.gif

EASL8.gif

EASL9.gif

EASL10.gif